We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant

Delisted

TROVW was delisted on the 30th of May, 2017.

4 hedge funds and large institutions have $2.18M invested in TrovaGene, Inc. Warrant in 2013 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+4
Holders Change %
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$2.05M +$1.55M +495,400 New
Morgan Stanley
2
Morgan Stanley
New York
$62K +$47.1K +15,000 New
Neuberger Berman Group
3
Neuberger Berman Group
New York
$62K +$47.1K +15,000 New
TRCT
4
Tower Research Capital (TRC)
New York
$1K +$587 +187 New

TROVW Hedge Fund Activity: Q2 2013 in Review

4 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q2 2013, worth a combined $2.18M.

Buyers outnumbered sellers: 4 funds opened new TROVW positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.18M of TrovaGene, Inc. Warrant stock for Q2 2013.
  • 4 funds opened new TrovaGene, Inc. Warrant positions in Q2 2013 and 0 closed out, a net change of +4 holders.

Based on aggregated 13F filings for Q2 2013.